The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
30S subunit recognition and G1405 modification by the aminoglycoside-resistance 16S ribosomal RNA methyltransferase RmtC
Open accessPreprint — published as 10.1073/pnas.2304128120 · Paper page
Abstract
Acquired ribosomal RNA (rRNA) methylation has emerged as a significant mechanism of aminoglycoside resistance in pathogenic bacterial infections. Modification of a single nucleotide in the ribosome decoding center by the aminoglycoside-resistance 16S rRNA (m 7 G1405) methyltransferases effectively blocks the action of all 4,6-deoxystreptamine ring-containing aminoglycosides, including the latest generation of drugs. To define the molecular basis of 30S subunit recognition and G1405 modification by these enzymes, we used a S -adenosyl-L-methionine (SAM) analog to trap the complex in a post-catalytic state to enable determination of an overall 3.0 Å cryo-electron microscopy structure of the m 7 G1405 methyltransferase RmtC bound to the mature Escherichia coli 30S ribosomal subunit. This structure, together with functional analyses of RmtC variants, identifies the RmtC N-terminal domain as critical for recognition and docking of the enzyme on a conserved 16S rRNA tertiary surface adjacent to G1405 in 16S rRNA helix 44 (h44). To access the G1405 N7 position for modification, a collection of residues across one surface of RmtC, including a loop that undergoes a disorder to order transition upon 30S subunit binding, induces significant distortion of h44. This distortion flips G1405 into the enzyme active site where it is positioned for modification by two almost universally conserved RmtC residues. These studies expand our understanding of ribosome recognition by rRNA modification enzymes and present a more complete structural basis for future development of strategies to inhibit m 7 G1405 modification to re-sensitize bacterial pathogens to aminoglycosides. Significance: Increasing prevalence of bacterial antibiotic resistance threatens our ability to treat bacterial infections and with it, many other facets of modern healthcare. For the ribosome-targeting aminoglycoside antibiotics, diverse pathogenic bacteria have acquired ribosomal RNA (rRNA) methyltransferase enzymes that confer exceptionally high-level resistance through site-specific modification of the drug binding site. Here, we define the molecular basis for ribosomal substrate recognition and modification by an enzyme (RmtC) representing the most clinically prevalent methyltransferase family. Specifically, RmtC exploits a conserved rRNA surface for binding and induces significant disruption of the rRNA structure to capture the target nucleotide for modification via a “base flipping” mechanism. These insights also present a platform for methyltransferase inhibitor development to extend usefulness of aminoglycoside antibiotics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Highly accurate protein structure prediction with AlphaFold
Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O., Tunyasuvunakool, K., Bates, R., Žídek, A., Potapenko, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03819-2 · Cited by 43,764
Research works printed but not linked: 48
- E. Peterson , P. Kaur , Antibiotic Resistance Mechanisms in Bacteria: Relationships Between Resistance Determinants of Antibiotic Producers, Environmental Bacteria, and Clinical Pathogens. Frontiers in Microbiology 9 (2018). · DOI
- 10.1039/c5md00344j · DOI
- 10.1101/cshperspect.a027029 · DOI
- 10.1261/rna.2314311 · DOI
- 10.1128/AAC.00926-07 · DOI
- 10.1016/j.drup.2012.05.001 · DOI
- 10.1038/327389a0 · DOI · Paper page
- 1965, Misreading of RNA Codewords Induced by Aminoglycoside Antibiotics, Molecular Pharmacology, 1, 93
- 10.1016/0006-291X(78)91493-6 · DOI
- 10.1016/0006-291X(78)90178-X · DOI
- 10.1038/35030019 · DOI · Paper page
- 2002, Crystal structure of a complex between the aminoglycoside tobramycin and an oligonucleotide containing the ribosomal decoding a site, Cell Chemical Biology, 9, 747
- 10.1126/science.1060612 · DOI · Paper page
- 10.1016/j.idc.2020.06.002 · DOI
- 10.1016/j.idc.2016.02.011 · DOI
- 10.1093/nar/gkq1033 · DOI
- 10.1093/nar/gkq627 · DOI
- 10.1128/AAC.00056-15 · DOI
- 10.1093/nar/gkv1306 · DOI
- 10.1016/j.jmb.2009.03.034 · DOI
- 10.1093/nar/gkq122 · DOI
- 10.1073/pnas.1402789111 · DOI
- 10.1074/jbc.RA119.011181 · DOI
- 2017, Substrate Recognition and Modification by a Pathogen-Associated Aminoglycoside Resistance 16S rRNA Methyltransferase, Antimicrobial Agents and Chemotherapy, 61, e00077
- E. M. Maksimova et al., RbfA Is Involved in Two Important Stages of 30S Subunit Assembly: Formation of the Central Pseudoknot and Docking of Helix 44 to the Decoding Center. Int J Mol Sci 22 (2021). · DOI
- 10.1016/S0968-0004(03)00090-2 · DOI · Paper page
- S. Hong , X. Cheng , DNA base flipping: a general mechanism for writing, reading, and erasing DNA modifications. DNA Methyltransferases-Role and Function, 321-341 (2016). · DOI
- 2022, 50S subunit recognition and modification by the Mycobacterium tuberculosis ribosomal RNA methyltransferase TlyA, Proceedings of the National Academy of Sciences of the United States of America, 119, e2120352119, 10.1073/pnas.2120352119 · DOI
- 10.1093/nar/gkab430 · DOI
- 2022, Decoding the Mechanism of Specific RNA Targeting by Ribosomal Methyltransferases, ACS Chem Biol, 17, 829, 10.1021/acschembio.1c00732 · DOI
- 10.1093/nar/gkz505 · DOI
- 10.1261/rna.1618809 · DOI
- 10.1128/AAC.06066-11 · DOI
- 10.1261/rna.042572.113 · DOI
- 2017, Emergence of rmtC and rmtF 16S rRNA Methyltransferase in Clinical Isolates of Pseudomonas aeruginosa, Indian Journal of Medical Microbiology, 35, 282, 10.4103/ijmm.IJMM_16_231 · DOI
- 10.1016/j.jsb.2012.09.006 · DOI · Paper page
- 10.1038/nmeth.2472 · DOI
- 10.1016/j.jsb.2015.11.003 · DOI
- T. Nakane , D. Kimanius , E. Lindahl , S. H. Scheres , Characterisation of molecular motions in cryo-EM single-particle data by multi-body refinement in RELION. Elife 7 (2018). · DOI
- 10.1261/rna.075846.120 · DOI
- 10.1073/pnas.1413731111 · DOI
- 10.1016/j.ymeth.2011.07.005 · DOI
- 10.1107/S2059798317003382 · DOI
- 10.1107/S0907444910007493 · DOI · Paper page
- 2021, AlphaFold Protein Structure Database: massively expanding the structural coverage of protein-sequence space with high-accuracy models, Nucleic Acids Research, 50, D439
- 10.1002/jcc.20084 · DOI
- 10.1002/pro.3235 · DOI · Paper page
- 10.1093/molbev/msy096 · DOI
Metadata
- Authors
- Srinivas, P., Nosrati, M., Zelinskaya, N., Dey, D., Comstock, L. R., Dunham, C. M., & Conn, G. L.
- Affiliations
- Emory University (US)
- Wake Forest University (US)
- Corresponding author
- Dunham, Christine M.
- Conn, Graeme L.
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- openRxiv
- Published
- 2023-03-13
- Volume
- 120
- Issue
- 25
- Pages
- e2304128120-e2304128120
- ISSN
- 0027-8424 (ISSN-L)
- PMC
- PMC10288597
- OpenAlex
- W4380302619
- Cited by
- 20
- References
- 1
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 6 · 2023: 2
- FWCI
- 1.77
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion, cc-by-nc-nd)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion)
- PubMed Central (submittedVersion, cc-by-nd)
- Funders
- U.S. Department of Energy (grid.436923.9, 436923.9)
- Burroughs Wellcome Fund
- Oregon Health and Science University (grid.436923.9, 436923.9)
- Emory University
- National Institutes of Health
- Office of Science (grid.436923.9)
- Emory College of Arts and Sciences, Emory University
- National Institute of General Medical Sciences (U24GM129547, T32GM008602)
- National Institute of Allergy and Infectious Diseases (R01AI088025, T32AI106699)
- Biological and Environmental Research (grid.436923.9)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA modifications and cancer
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Keywords
- rmtC, 16S rRNA methylase, aminoglycoside resistance, 30S ribosomal subunit, Escherichia coli, enzyme-substrate complex structure, N-terminal domain
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review